You are here

Clinical Trials: Cord Blood

Conditions: Post-Acute COVID-19 Syndrome
Interventions: Biological: Stem Cell
Sponsors: Charles Cox; CBR Systems, Inc.
Not yet recruiting
Conditions: Leukemia; Stem Cell Transplant; Cord Blood
Interventions: Procedure: applying of FLU+CY post-HSCT
Sponsors: Nanfang Hospital, Southern Medical University
Conditions: Hematopoietic Malignancy; Relapse/Recurrence; Hematopoietic Stem Cell Transplantation
Interventions: Procedure: Umbilical Cord Blood Transplantation
Sponsors: The First Affiliated Hospital of Soochow University
Conditions: Myelodysplastic Syndromes
Interventions: Biological: Unrelated Umbilical Cord Blood; Drug: Venetoclax; Drug: Decetabine; Drug: Azacitidine
Sponsors: Anhui Provincial Hospital
Conditions: Acute Myelocytic Leukemia
Interventions: Biological: Unrelated umbilical cord blood; Drug: Chemotherapy drugs including Venetoclax, Decetabine and Azacitidine
Sponsors: Anhui Provincial Hospital
Conditions: Osteoarthritis, Knee
Interventions: Biological: Knee aspiration + UCB-MSCs; Other: Knee aspiration
Sponsors: University Medical Centre Ljubljana; Blood Transfusion Centre of Slovenia
Conditions:   Acute Leukemia of Ambiguous Lineage;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Blastic Plasmacytoid Dendritic Cell Neoplasm;   Hematopoietic and Lymphoid System Neoplasm;   Mixed Phenotype Acute Leukemia;   Myelodysplastic Syndrome;   Myeloproliferative Neoplasm;   Non-Hodgkin Lymphoma
Interventions:   Procedure: Biospecimen Collection;   Procedure: Bone Marrow Aspirate;   Drug: Cyclophosphamide;   Drug: Cyclosporine;   Procedure: Diagnostic Imaging;   Procedure: Echocardiography;   Drug: Fludarabine Phosphate;   Procedure: Multigated Acquisition Scan;   Drug: Mycophenolate Mofetil;   Other: Survey Administration;   Drug: Thiotepa;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation
Sponsors:   Fred Hutchinson Cancer Center;   National Cord Blood Network
Not yet recruiting
Conditions:   Refractory Diabetic Foot;   Human Cord Blood-derived Mononuclear Cells;   Efficacy;   Safety;   Local Injection
Intervention:   Biological: human cord blood-derived mononuclear cells (HCB-MNCs)
Sponsors:   The First Affiliated Hospital with Nanjing Medical University;   Shandong Qilu Stem Cells Engineering Co., Ltd.
Conditions:   Hematopoietic Stem Cell Transplantation;   Malignant Hematological Diseases
Intervention:   Procedure: Umbilical Cord Blood Transplantation
Sponsor:   The First Affiliated Hospital of Soochow University
Conditions:   Acute Myelogenous Leukemia (AML);   Acute Lymphoblastic Leukemia (ALL);   Chronic Myelogenous Leukemia (CML);   Myelodysplastic Syndromes (MDS);   Myeloproliferative Disorder;   Non-Hodgkin's Lymphoma
Interventions:   Drug: Conditioning Chemotherapy;   Biological: Cord blood graft
Sponsor:   Memorial Sloan Kettering Cancer Center